Behavioral responses to social stress in noradrenaline transporter knockout mice: Effects on social behavior and depression

Brain Research Bulletin

Volumn 58, Issue 3, 2002, Pages 279-284

  Haller, József ^a   Bakos, Nikoletta ^a   Rodriguiz, Ramona M ^b   Caron, Marc G ^b   Wetsel, William C ^b   Liposits, Zsolt ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Depression; Genes; NET KO; Noradrenaline transporter; Rat; Stress

Indexed keywords

NORADRENALIN TRANSPORTER; COTRANSPORTER; NORADRENALIN; SLC6A2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DEPRESSION; GENE DISRUPTION; KNOCKOUT MOUSE; LEARNING; MALE; NONHUMAN; PRIORITY JOURNAL; SOCIAL BEHAVIOR; SOCIAL PROBLEM; WEIGHT GAIN; AGGRESSION; ANIMAL; ANIMAL BEHAVIOR; BRAIN; DISEASE MODEL; GENETICS; MENTAL STRESS; METABOLISM; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

AGGRESSION; ANIMAL; BEHAVIOR, ANIMAL; BRAIN; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; MICE; MICE, KNOCKOUT; NOREPINEPHRINE; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL; SUPPORT, NON-U.S. GOV'T; SYMPORTERS; ANIMALS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 0035997057     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(02)00789-X     Document Type: Article

References (43)

1. Genetic approaches to studying norepinephrine function: Knockout of the mouse norepinephrine transporter gene
2. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants
3. The catecholamine hypothesis - A review of the supporting evidence
4. Noradrenaline in basic models of depression
5. Is there a role for a pure noradrenergic drug in the treatment of depression?
6. Histochemical studies on the effect of (positive)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine
7. Rational use of psychotropic drugs. IV. Antidepressants
8. Brain noradrenaline and the mechanisms of action of antidepressant drugs
9. Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: An autoradiographic study
10. The role of corticotropin releasing factor in depressive illness: A critical review
11. Chronic treatment with the antidepressant amitriptyline decreases CRF-R1 receptor mRNA levels in the rat amygdala
12. Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression
13. Novel therapeutic approaches beyond the serotonin receptor
14. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus
15. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus
16. Psychosocial stress in tree shrews: Clomipramine counteracts behavioral and endocrine changes
17. Chronic psychosocial stress and antidepressant treatment in tree shrews: Time-dependent behavioral and endocrine effects
18. Social model of depression in mice of C57BL/6J strain
19. Behavioral and autonomic responses to intermittent social stress: Differential protection by clonidine and metoprolol
20. Experimental animal modeling of depression and anxiety
21. Behavioural despair in rats: A new model sensitive to antidepressant treatments
22. Animal models of depression: Utility for transgenic research
23. Behavioral despair in mice after prenatal stress
24. 3H]-tomoxetine
25. Reduction of depressive-like behavior in mice lacking angiotensinogen
26. Genetic alteration of the alpha-2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels
27. Karyotype and intermale aggression in wild house mice: Ecology and speciation
28. The integrity of the social hierarchy in mice following administration of psychotropic drugs
29. Catecholaminergic involvement in the control of aggression: Hormones, the peripheral sympathetic, and central noradrenergic systems
30. Biphasic effects of typical antidepressants and mianserin, an atypical antidepressant, on aggressive behavior in socially isolated mice
31. Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline, and fluvoxamine. I. Social interactions
32. Do alpha-2 adrenoceptors modify coping strategies in rats?
33. Individual differences in plasma catecholamine and corticosterone stress responses of wild-type rats: Relationship with aggression
34. The social competition hypothesis of depression
35. Is antidepressant efficacy revealed by drug-induced changes in rat behaviour exhibited during social interaction?
36. Potentiation of the time-dependent, antidepressant-induced changes in the agonistic behaviour of resident rats by the 5-HT1A receptor antagonist, WAY-100635
37. Ethological strategies for defense in animals and humans: Their role in some psychiatric disorders
38. Stress ulcer susceptibility and depression in Wistar-Kyoto (WKY) rats
39. Passive-avoidance behavior in Wistar-Kyoto (WKY), Wistar, and Fischer-344 rats
40. Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine
41. The relation of castration, androgen therapy and pre-test fighting experience to competitive aggression in male C57BL/10 mice
42. Behavioral consequences of agonistic experience in rats: Sex differences and the effects of testosterone
43. Acute effects of glucocorticoids: Behavioral and pharmacological perspectives